These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 2426419)

  • 1. High-dose versus low-dose vinblastine in cisplatin-vinblastine-bleomycin combination chemotherapy of non-seminomatous testicular cancer: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group.
    Stoter G; Sleyfer DT; ten Bokkel Huinink WW; Kaye SB; Jones WG; van Oosterom AT; Vendrik CP; Spaander P; de Pauw M; Sylvester R
    J Clin Oncol; 1986 Aug; 4(8):1199-206. PubMed ID: 2426419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors for favorable outcome in disseminated germ cell tumors.
    Birch R; Williams S; Cone A; Einhorn L; Roark P; Turner S; Greco FA
    J Clin Oncol; 1986 Mar; 4(3):400-7. PubMed ID: 2419524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study.
    Wozniak AJ; Samson MK; Shah NT; Crawford ED; Ford CD; Altman SJ; Stephens RL; Natale RB; Bouroncle BA; Blumenstein BA
    J Clin Oncol; 1991 Jan; 9(1):70-6. PubMed ID: 1702148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage III and bulky stage II nonseminomatous testicular cancer.
    Pizzocaro G; Salvioni R; Pasi M; Zanoni F; Milani A; Pilotti S; Monfardini S
    Cancer; 1985 Jul; 56(2):249-55. PubMed ID: 2408728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of good-risk disseminated testicular cancer with cisplatin, bleomycin, and reduced-dose vinblastine.
    Pizzocardo G; Salvioni R; Zanoni F; Milani A; Piva L
    Cancer; 1986 Jun; 57(11):2114-8. PubMed ID: 2421865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 20% dose reduction of the original CISCA/VB regimen allows better tolerance and similar survival rate in disseminated testicular non-seminomatous germ-cell tumors: final results of a phase III randomized trial.
    Fizazi K; Do KA; Wang X; Finn L; Logothetis CJ; Amato RJ
    Ann Oncol; 2002 Jan; 13(1):125-34. PubMed ID: 11863094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin combination chemotherapy for advanced germ-cell testicular tumours.
    Taylor RE; Duncan W; Davey P; Munro AJ; Cornbleet MA
    Br J Urol; 1985 Oct; 57(5):567-73. PubMed ID: 2415203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year survival of patients with disseminated nonseminomatous testicular cancer treated with cisplatin, vinblastine, and bleomycin.
    Stoter G; Vendrik CP; Struyvenberg A; Sleyfer DT; Vriesendorp R; Schraffordt Koops H; van Oosterom AT; ten Bokkel Huinink WW; Pinedo HM
    Cancer; 1984 Oct; 54(8):1521-4. PubMed ID: 6206937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT).
    de Bono JS; Paul J; Simpson A; Anthoney A; Kirk D; Underwood M; Graham J; Kaye SB
    Br J Cancer; 2000 Aug; 83(4):426-30. PubMed ID: 10945485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum tumor markers in patients with testicular cancer after induction chemotherapy due to a reservoir of markers in cystic differentiated mature teratoma.
    van der Gaast A; Hoekstra JW; Croles JJ; Splinter TA
    J Urol; 1991 Apr; 145(4):829-31. PubMed ID: 1706441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of testicular cancer: a new and improved model.
    Einhorn LH
    J Clin Oncol; 1990 Nov; 8(11):1777-81. PubMed ID: 1700077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second malignancy after cisplatin, vinblastine, and bleomycin (PVB) chemotherapy: a case report.
    Mead GM; Green JA; Macbeth FR; Williams CJ; Whitehouse JM; Buchanan R
    Cancer Treat Rep; 1983 Apr; 67(4):410. PubMed ID: 6189603
    [No Abstract]   [Full Text] [Related]  

  • 13. [Case report of a non-seminomatous testicular neoplasm indicating marked efficacy of a combination chemotherapy of VBL, ACTD, BLM, CDDP and EX (VAB-4 combination therapy)].
    Hayashi M; Ebihara K; Urano E
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2775-7. PubMed ID: 6210063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tumor markers as a prognostic factor of the response to treatment in cancer of the testicle].
    Germa Lluch JR; Bastus Piulats R
    Actas Urol Esp; 1987; 11(3):293-8. PubMed ID: 2444075
    [No Abstract]   [Full Text] [Related]  

  • 15. A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.
    Bosl GJ; Geller NL; Bajorin D; Leitner SP; Yagoda A; Golbey RB; Scher H; Vogelzang NJ; Auman J; Carey R
    J Clin Oncol; 1988 Aug; 6(8):1231-8. PubMed ID: 2457657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-seminomatous testicular germ cell tumours. Preliminary analysis of ongoing trials in the DATECA Study.
    Rørth M; von der Maase H; Sandberg Nielsen E; Schultz HP; Svennekjaer IL
    Acta Radiol Oncol; 1984; 23(4):295-304. PubMed ID: 6208750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer. A Southwest Oncology Group study.
    Samson MK; Rivkin SE; Jones SE; Costanzi JJ; LoBuglio AF; Stephens RL; Gehan EA; Cummings GD
    Cancer; 1984 Mar; 53(5):1029-35. PubMed ID: 6198064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis.
    Logothetis CJ; Samuels ML; Selig D; Swanson D; Johnson DE; von Eschenbach AC
    J Clin Oncol; 1985 Mar; 3(3):326-35. PubMed ID: 2579213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of retroperitoneal residual tumor after PVB chemotherapy of nonseminomatous testicular tumors.
    Gelderman WA; Koops HS; Sleijfer DT; Oosterhuis JW; Oldhoff J
    Cancer; 1986 Oct; 58(7):1418-21. PubMed ID: 2427186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient rise in tumor marker after initial adjuvant chemotherapy for testicular cancer.
    Wolf DJ; Williams JJ
    Urology; 1982 Jul; 20(1):50-2. PubMed ID: 6180542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.